<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2021.775346</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>STING Signaling Drives Production of Innate Cytokines, Generation of CD8<sup>+</sup> T Cells and Enhanced Protection Against <italic>Trypanosoma cruzi</italic> Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vieira</surname>
<given-names>Raquel de Souza</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/669071"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nascimento</surname>
<given-names>Marilda Savoia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1602166"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Noronha</surname>
<given-names>Isa&#xfa; Henrique</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1272957"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasconcelos</surname>
<given-names>Jos&#xe9; Ronnie Carvalho</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/74188"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Benvenuti</surname>
<given-names>Luiz Alberto</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/378170"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barber</surname>
<given-names>Glen N.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/288418"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>C&#xe2;mara</surname>
<given-names>Niels Olsen Saraiva</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/174754"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalil</surname>
<given-names>Jorge</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/113056"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cunha-Neto</surname>
<given-names>Edecio</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/83315"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Almeida</surname>
<given-names>Rafael Ribeiro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/290384"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o, Faculdade de Medicina da Universidade de S&#xe3;o Paulo</institution>, <addr-line> S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Laborat&#xf3;rio de Vacinas Recombinantes, Departamento de Bioci&#xea;ncias, Universidade Federal de S&#xe3;o Paulo</institution>, <addr-line> Santos</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Divis&#xe3;o de Patologia, Instituto do Cora&#xe7;&#xe3;o (INCOR), Faculdade de Medicina, Universidade de S&#xe3;o Paulo</institution>, <addr-line> S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Cell Biology, University of Miami</institution>, <addr-line>Miami, FL</addr-line>, <country>United States</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Laborat&#xf3;rio de Imunologia Experimental e Cl&#xed;nica, Departamento de Cl&#xed;nica M&#xe9;dica, Faculdade de Medicina, Universidade Federal de S&#xe3;o Paulo</institution>, <addr-line> S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Laborat&#xf3;rio de Imunologia de Transplantes, Departamento de Imunologia, Instituto de Ci&#xea;ncias Biom&#xe9;dicas, Universidade de S&#xe3;o Paulo</institution>, <addr-line> S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Disciplina de Imunologia Cl&#xed;nica e Alergia, Faculdade de Medicina da Universidade de S&#xe3;o Paulo</institution>, <addr-line> S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Instituto de Investiga&#xe7;&#xe3;o em Imunologia (III), Instituto Nacional de Ci&#xea;ncia e Tecnologia (INCT)</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Tiago W. P. Mineo, Federal University of Uberlandia, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ana Rosa P&#xe9;rez, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Argentina; Yang Cheng, Jiangnan University, China; Galadriel Hovel-Miner, George Washington University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Rafael Ribeiro Almeida, <email xlink:href="mailto:rafaelbio13@alumni.usp.br">rafaelbio13@alumni.usp.br</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>775346</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>12</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Vieira, Nascimento, Noronha, Vasconcelos, Benvenuti, Barber, C&#xe2;mara, Kalil, Cunha-Neto and Almeida</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Vieira, Nascimento, Noronha, Vasconcelos, Benvenuti, Barber, C&#xe2;mara, Kalil, Cunha-Neto and Almeida</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>A variety of signaling pathways are involved in the induction of innate cytokines and CD8<sup>+</sup> T cells, which are major players in protection against acute <italic>Trypanosoma cruzi</italic> infection. Previous data have demonstrated that a TBK-1/IRF3-dependent signaling pathway promotes IFN-&#x3b2; production in response to <italic>Trypanosoma cruzi</italic>, but the role for STING, a main interactor of these proteins, remained to be addressed. Here, we demonstrated that STING signaling is required for production of IFN-&#x3b2;, IL-6, and IL-12 in response to <italic>Trypanosoma cruzi</italic> infection and that STING absence negatively impacts activation of IRF-dependent pathways in response to the parasite. We reported no significant activation of IRF-dependent pathways and cytokine expression in RAW264.7 macrophages in response to heat-killed trypomastigotes. In addition, we showed that STING is essential for <italic>T. cruzi</italic> DNA-mediated induction of IFN-&#x3b2;, IL-6, and IL-12 gene expression in RAW264.7 macrophages. We demonstrated that STING-knockout mice have significantly higher parasitemia from days 5 to 8 of infection and higher heart parasitism at day 13 after infection. Although we observed similar heart inflammatory infiltrates at day 13 after infection, IFN-&#x3b2;, IL-12, CXCL9, IFN-&#x3b3;, and perforin gene expression were lower in the absence of STING. We also showed an inverse correlation between parasite DNA and the expression of CXCL9, IFN-&#x3b3;, and perforin genes in the hearts of infected animals at day 13 after infection. Finally, we reported that&#xa0;STING signaling is required for splenic IFN-&#x3b2; and IL-6 expression early after infection and that STING deficiency results in lower numbers of splenic parasite-specific IFN-&#x3b3; and IFN-&#x3b3;/perforin-producing CD8<sup>+</sup> T cells, indicating a pivotal role for STING signaling in immunity to <italic>Trypanosoma cruzi</italic>.</p>
</abstract>
<kwd-group>
<kwd>STING</kwd>
<kwd>IFN-&#x3b2;</kwd>
<kwd>IL-6</kwd>
<kwd>IL-12</kwd>
<kwd>CD8<sup>+</sup> T cell</kwd>
<kwd>
<italic>Trypanosoma cruzi</italic>
</kwd>
</kwd-group>
<contract-sponsor id="cn001">Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico<named-content content-type="fundref-id">10.13039/501100003593</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo<named-content content-type="fundref-id">10.13039/501100001807</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo<named-content content-type="fundref-id">10.13039/501100001807</named-content>
</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="74"/>
<page-count count="13"/>
<word-count count="6284"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Chagas disease is caused by the flagellate protozoan <italic>Trypanosoma cruzi</italic> (<italic>T. cruzi</italic>) and affects over 8 million people worldwide. The acute infection results in mild symptoms, which include fever and muscle pain. Most individuals evolve to a chronic asymptomatic infection with low parasitism, but 30%&#x2013;40% either have or will develop cardiomyopathy, digestive megasyndromes, or both (<xref ref-type="bibr" rid="B1">1</xref>). While effective innate and adaptive immunity promotes parasite control, imbalanced host immune responses to persistent infection are suggested to favor inflammation and the development of chronic Chagas pathology (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Toll-like receptors (TLRs), nucleotide-binding oligomerization domain 1 (NOD1) receptor, and NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) have been described as major contributors to innate immunity against <italic>T. cruzi</italic>, promoting production of cytokines and nitric oxide (NO) (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). Interleukin (IL)-6 and IL-12 are crucial cytokines for immune-mediated resistance to <italic>T. cruzi</italic>, as shown either by infection of genetically deficient mice or <italic>in vivo</italic> cytokine neutralization (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>). TLR signaling may also result in interferon-&#x3b2; (IFN-&#x3b2;) production, which has been previously implicated in parasite control in dendritic cells and macrophages, in addition to increasing resistance to infection in mice (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>In terms of adaptive immunity, T helper 1 (Th1) cells figure as an important source of IFN-&#x3b3;, promoting activation of infected macrophages and providing help for other effector cells against <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). Unlike CD4<sup>+</sup> T cells, <italic>T. cruzi</italic>-specific CD8<sup>+</sup> T cells are essential for infection control, either by promoting protection during early contact with the parasite or by limiting <italic>T. cruzi</italic> burden during chronic infection (<xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B23">23</xref>). While perforin-producing CD8<sup>+</sup> T cells have a contradictory role against <italic>T. cruzi</italic>, being related to myocarditis and heart damage in chronically infected mice (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>), IFN-&#x3b3;-producing CD8<sup>+</sup> T cells have been indicated as protective in both experimental models and patients (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>DNA sensing is highly conserved as a cellular mechanism of response to pathogens and can be mediated by a variety of molecules, such as Z-DNA-binding protein 1 (ZBP1), leucin-rich repeat flightless-interacting protein 1 (LRRFIP1), DEAD-box helicase 41 (DDX41), IFN-&#x3b3;-inducible protein 16 (IFI16), and the cyclic-GMP-AMP synthase (cGAS), leading to activation of stimulator of IFN genes (STING) (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>). Activation of STING leads to conformational changes that trigger its oligomerization and translocation from the endoplasmic reticulum to the Golgi apparatus (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). During translocation, STING recruits and activates TANK-binding kinase 1 (TBK-1), which in turn phosphorylates the interferon-regulatory factor 3 (IRF3), enabling its dimerization and translocation to the nucleus to induce type I IFN (IFN-&#x3b1; and IFN-&#x3b2;) gene expression (<xref ref-type="bibr" rid="B36">36</xref>). Alternatively, STING activation results in NF-&#x3ba;B translocation to the nucleus, where it functions together with IRF3 and other transcription factors to induce the expression of type I IFN and inflammatory cytokines such as tumor necrosis factor &#x3b1; (TNF-&#x3b1;), IL-1&#x3b2;, and IL-6 (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). This ability of STING in orchestrating multiple DNA sensing pathways has been implicated not only in innate immunity to multiple pathogens but also in promoting effector CD8<sup>+</sup> T cells against cancer (<xref ref-type="bibr" rid="B39">39</xref>&#x2013;<xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>The STING ligand cyclic di-AMP (c-di-AMP) has been successfully used as an adjuvant to increase immunogenicity of anti-<italic>T. cruzi</italic> vaccines and to promote protection against infection in mice (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). It has also been demonstrated that <italic>in vitro</italic> cGAS inhibition limits macrophage response to extracellular vesicles derived from <italic>T. cruzi</italic>-infected cells (<xref ref-type="bibr" rid="B44">44</xref>). In addition, previous data indicated that TBK-1 and IRF3 are involved in IFN-&#x3b2; production during <italic>in vitro T. cruzi</italic> infection (<xref ref-type="bibr" rid="B45">45</xref>). Therefore, we hypothesized that STING signaling would play an important role in mediating production of innate cytokines and generation of CD8<sup>+</sup> T cells against <italic>T. cruzi</italic>, promoting protection against acute infection.</p>
<p>Here, we demonstrated that STING signaling is required for expression of IFN-&#x3b2;, IL-6, and IL-12 in response to <italic>T. cruzi</italic> infection in RAW264.7 macrophages and that STING absence negatively impacts activation of IRF-dependent pathways in response to the parasite. We reported that heat-killed trypomastigotes promoted no significant activation of IRF-dependent pathways and cytokine production in RAW264.7 macrophages. In addition, we showed that STING is essential for <italic>T. cruzi</italic> DNA-mediated induction of IFN-&#x3b2;, IL-6, and IL-12 gene expression in RAW264.7 macrophages. Our results also revealed that STING signaling promotes production of key innate cytokines and generation of parasite-specific CD8<sup>+</sup> T cells in mice, contributing to better control of parasitemia and heart parasitism.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Cell Culture, <italic>Trypanosoma cruzi</italic> Infection, and Cellular Transfections</title>
<p>Rhesus monkey kidney epithelial cells (LLC-MK2 cells) (ATCC) were routinely cultured in high-glucose Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM), supplemented with 10% fetal bovine&#xa0;serum (FBS) (Thermo Fisher, Waltham, MA, USA) (DMEM10) at 37&#xb0;C and 5% CO<sub>2</sub>. These cells were infected with the <italic>Trypanosoma cruzi</italic> Y stain in high-glucose DMEM, supplemented with 2% FBS (DMEM2) (Thermo Fisher) to maintain the parasite.</p>
<p>Supernatant of <italic>T. cruzi</italic>-infected LLC-MK2 cells was collected, centrifuged in a 15-ml tube (Corning, Corning, NY, USA) at 1,350&#xd7;<italic>g</italic> for 10 min and washed twice with DMEM2. After the last centrifugation, the pellet was left in DMEM2 for 2 h at 37&#xb0;C and 5% CO<sub>2</sub> to allow live trypomastigotes to swim. The supernatant containing live trypomastigotes was collected and filtered in a bottle top 0.22-&#xb5;m filter (Corning). The filter was washed with DMEM2 to resuspend the live trypomastigotes, which were transferred to a new 15-ml tube and incubated at 56&#xb0;C for 10 min. Parasite DNA was obtained by incubating approximately 200 million heat-killed trypomastigotes in 500 &#xb5;l of lysis buffer (Tris.HCl 0.1 M, pH 8.5; EDTA 5 mM, pH 8.0; NaCl 0.2 M, SDS 0.2%, and 100 &#xb5;g of proteinase K in water) at 37&#xb0;C and 600 rpm for 18 h, followed by precipitation with isopropanol at 8,600&#xd7;<italic>g</italic> for 5 min, washing with ethanol at 70%, centrifugation at 8,600&#xd7;<italic>g</italic> for 5 min, and resuspension in 25 &#xb5;l of DNAse/RNAse-free water. The ratios of absorbance at 260/280 and 260/230 nm were used to assess the purity of DNA with a Nanodrop 2000 (Thermo Fisher). The parasite DNA used in transfection experiments had 260/280 and 260/230 ratios of 1.92 and 2.21, respectively.</p>
<p>RAW264.7-Lucia&#x2122; ISG and RAW264.7-Lucia&#x2122; ISG-STING-KO macrophages (<italic>Invivo</italic>Gen, Toulouse, France) were plated in 24-well plates (Corning) at a density of 10<sup>5</sup> cells per well in 500 &#xb5;l of DMEM2 24 h before infection, exposure to heat-killed trypomastigotes, or transfections. The cells were incubated for 16 h with 3 &#xd7; 10<sup>6</sup> live or heat-killed trypomastigotes per well in 300 &#xb5;l of DMEM2, washed with PBS (Thermo Fisher), and incubated for additional 24 h in 300 &#xb5;l of DMEM2. Supernatant was collected and total RNA extracted. Alternatively, the cells were transfected with 80 ng of parasite DNA complexed with lipofectamine 2000 (Thermo Fisher) in 300 &#xb5;l of OPTIMEM (Thermo Fisher) per well, accordingly to manufacturer&#x2019;s instructions. As experimental controls, the cells were transfected either with 1.0 &#x3bc;g/ml of c-di-GMP (<italic>Invivo</italic>Gen) or 0.5 &#x3bc;g/ml of Poly I:C (<italic>Invivo</italic>Gen) complexed with lipofectamine 2000 in 300 &#xb5;l of OPTIMEM. Lipofectamine 2000 and OPTMEM were used in negative control wells. Supernatant was collected and total RNA extracted 24 h after transfection.</p>
</sec>
<sec id="s2_2">
<title>Luciferase Activity and Cytokine Measurement</title>
<p>Twenty microliters of supernatant from infected, heat-killed parasite-exposed or transfected RAW264.7-Lucia&#x2122; ISG and RAW264.7-Lucia&#x2122; ISG-STING-KO macrophages were mixed with 50 &#x3bc;l of QUANTI-Luc&#x2122; (<italic>Invivo</italic>Gen) and immediately read in a Smart Line TL luminometer (Titertek Berthold, Pforzheim, Germany), with an acquisition time of 1 s for determination of luciferase activity. The detection of IFN-&#x3b2;, IL-6, and IL-12 cytokines in the supernatant of infected RAW264.7-Lucia&#x2122; ISG and RAW264.7-Lucia&#x2122; ISG-STING-KO macrophages was performed using the Mouse Custom ProcartaPlex kit (Thermo Fisher), accordingly to manufacturer&#x2019;s instructions. The samples were read with a MagPix Luminex system (Merck Millipore, Burlington, MA, USA) and analyzed using the Milliplex Analyst software (Merck Millipore).</p>
</sec>
<sec id="s2_3">
<title>Ethics Statement</title>
<p>The study was approved by the Ethics Committee on the Use of Animals (CEUA) of the Faculty of Medicine, University of Sao Paulo (FMUSP), under protocol number 1567/2020, and carried out in accordance with Brazilian Federal Law number 11,794 on scientific use of animals and the National Institutes of Health guide for the care and use of laboratory animals.</p>
</sec>
<sec id="s2_4">
<title>Mice and Experimental Infection</title>
<p>Six- to 8-week-old male wild-type BALB/c, wild-type C57BL6, and STING-KO mice with a C57BL6 background were maintained at the Tropical Medicine Institute II, Faculty of Medicine, University of Sao Paulo. BALB/c and C57BL6 mice were purchased from the Faculty of Medicine, University of Sao Paulo. STING-KO mice were kindly provided by Dr. Baber and are derived from his previously described laboratory colony (<xref ref-type="bibr" rid="B46">46</xref>). The animals were housed in groups of up to 5 per cage in a room with controlled light and temperature (12 h light/dark cycles, 21&#xb0;C &#xb1; 2&#xb0;C) and free access to food and water.</p>
<p>The <italic>Trypanosoma cruzi</italic> Y strain was maintained in BALB/c mice and used to infect wild-type C57BL6 and STING-KO mice. Blood was collected from euthanized BALB/c mice at the peak of infection and centrifuged at 200&#xd7;<italic>g</italic> for 10 min. The supernatant was collected, centrifuged at 3,800&#xd7;<italic>g</italic>, and the pellet of parasites resuspended in RPMI1640 (Thermo Fisher). Fifty thousand trypomastigotes in 200 &#xb5;l of RPMI1640 were intraperitoneally injected in each C57BL6 and STING-KO mouse. Parasitemia was monitored by counting the number of trypomastigotes in 5 &#xb5;l of fresh blood collected from the tail vein as previously described (<xref ref-type="bibr" rid="B47">47</xref>).</p>
</sec>
<sec id="s2_5">
<title>Nitrite Detection</title>
<p>RAW264.7-Lucia&#x2122; ISG and RAW264.7-Lucia&#x2122; ISG-STING-KO macrophages were plated and incubated with live trypomastigotes for 16 h, as previously described. The cells were washed with PBS and incubated for an additional 48 h in 300 &#xb5;l of high-glucose DMEM without phenol red (Nova Biotecnologia, Ribeirao Preto, Brazil). Alternatively, splenocytes from 4-, 7-, and 13-day-infected C57BL6 and STING-KO mice were incubated for 48 h at a density of 5 &#xd7; 10<sup>5</sup> cells in 200 &#xb5;l of high-glucose DMEM without phenol red per well. The supernatant was collected and centrifuged at 15,000&#xd7;<italic>g</italic> for 5 min. The Nitric Oxide Assay kit (Thermo Fisher) was used accordingly to manufacturer&#x2019;s instructions for total nitrate and nitrite detection with an Epoch spectrophotometer (BioTek, Winooski, VT, USA).</p>
</sec>
<sec id="s2_6">
<title>Real-Time PCR</title>
<p>Total RNA extraction from RAW264.7 macrophages, hearts, and spleens was performed using Trizol reagent (Thermo Fisher), RNeasy Fibrous Tissue kit (Qiagen, Hilden, Germany), and RNeasy mini kit (Qiagen), respectively. Synthesis of cDNA was performed using the Superscript II Reverse Transcriptase (Thermo Fisher), accordingly to manufacturer&#x2019;s instructions. Real-time PCR was performed using Power SyBr green master mix (Thermo Fisher) and a QuantStudio 12k thermocycler (Thermo Fisher) with the following parameters: 95&#xb0;C for 15 min, 40 cycles of 95&#xb0;C for 15 s, and 60&#xb0;C for 1 min. The primer sequences were as follows: HPRT1 forward 5&#x2032;-GTTGGGCTTACCTCACTGCT-3&#x2032;; HPRT1 reverse 5&#x2032;-GCAAAAAGCGGTCTGAGGAG-3&#x2032;; IFN-&#x3b2; forward 5&#x2032;-TGGGAGATGTCCTCAACTGC-3&#x2032;; IFN-&#x3b2; reverse 5&#x2032;-CCAGGCGTAGCTGTTGTACT-3&#x2032;; IL-6 forward 5&#x2032;-CCCCAATTTCCAATGCTCTCC-3&#x2032;; IL-6 reverse 5&#x2032;-GGATGGTCTTGGTCCTTAGCC-3&#x2032;; IL-12 forward 5&#x2032;-GAAGTCCAATGCAAAGGCGG-3&#x2032;; IL-12 reverse 5&#x2032;-GAACACATGCCCACTTGCTG-3&#x2032;; TNF-&#x3b1; forward 5&#x2032;-ATGGCCTCCCTCTCATCAGT-3&#x2032;; TNF-&#x3b1; reverse 5&#x2032;-TTTGCTACGACGTGGGCTAC-3&#x2032;; CXCL9 forward 5&#x2032;-CCAAGCCCCAATTGCAACAA-3&#x2032;; CXCL9 reverse 5&#x2032;-AGTCCGGATCTAGGCAGGTT-3&#x2032;; IFN-&#x3b3; forward 5&#x2032;-AGCAAGGCGAAAAAGGATGC-3&#x2032;; IFN-&#x3b3; reverse 5&#x2032;-TCATTGAATGCTTGGCGCTG-3&#x2032;; PRF1 forward 5&#x2032;-TGGTGGGACTTCAGCTTTCC-3&#x2032;; PRF1 reverse 5&#x2032;-GAAAAGGCCCAGGAGGAACA-3&#x2032;.</p>
<p>For detection of parasite DNA in the hearts of infected animals, we extracted DNA using the FlexiGene Kit (Qiagen), accordingly to manufacturer&#x2019;s instructions and used previously described primer sequences (<xref ref-type="bibr" rid="B48">48</xref>). Real-time quantitative PCR was performed using Power Sybr green Master mix and the Quanti Studio 3 thermocycler (Thermo Fisher). The &#x3b2;-actin gene was used as an endogenous control and the calculation of parasitism in the heart was based on a <italic>T. cruzi</italic> DNA dilution curve.</p>
</sec>
<sec id="s2_7">
<title>Preparation of TSKB20 Peptide</title>
<p>TSBK20 peptide (ANYKFTVL-NH2) was synthesized by manual solid phase peptide synthesis on NovaSyn TGR R resin (Merck) using the Fmoc/tBu strategy. 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) (Merck) and <italic>N</italic>,<italic>N</italic>-diisopropylethylamine (DIPEA) were used in the coupling reactions and <italic>N</italic>,<italic>N</italic>-dimethylformamide (DMF) was used as solvent. Purity (&gt;97%) was determined by RP-HPLC (Shimadzu, Kyoto, Japan). The peptide was resuspended in dimethyl sulfoxide (DMSO) at a stock concentration of 10 mg/ml and used in immunological assays at a concentration of 10 &#xb5;g/ml.</p>
</sec>
<sec id="s2_8">
<title>Flow Cytometry</title>
<p>Spleens from uninfected and 13-day-infected C57BL6 and STING-KO mice were aseptically removed and disrupted using 70 &#xb5;m Cell Strainer (Corning). Red blood cells were lysed using ACK lysis buffer (Thermo Fisher); the samples were centrifuged at 300&#xd7;<italic>g</italic> for 5 min and splenocytes resuspended in R10 medium (RPMI-1640 supplemented with 10% FBS, 2 mM <sc>l</sc>-glutamine, 1 mM sodium pyruvate, 1% vol/vol nonessential amino acid solution, 1% vol/vol vitamin solution, 40 &#xb5;g/ml of gentamicin, and 5 &#xd7; 10<sup>&#x2212;5</sup> M 2&#x3b2;-mercaptoethanol, all from Thermo Fisher). Splenocytes were plated in 96-well round-bottom plates (Corning) at a density of 0.5 &#xd7; 10<sup>6</sup> cells in 200 &#xb5;l of R10 medium and stimulated with 10 &#xb5;g/ml of the <italic>T. cruzi</italic> H2-K<sup>b</sup>-restricted peptide TSKB20 in the presence of 5 &#xb5;g/ml of brefeldin A (BioLegend, San Diego, CA, USA) for 14 h at 37&#xb0;C and 5% CO<sub>2</sub>. DMSO and PMA (50 ng/ml) plus ionomycin (500 ng/ml) (Sigma, St. Louis, MO, USA) were used as negative and positive control stimuli, respectively.</p>
<p>After stimulation, the cells were transferred to 96-well V-bottom plates (Corning), centrifuged at 300&#xd7;<italic>g</italic> for 5 min and stained with the monoclonal antibodies anti-CD3 APC-Cy7 (BD Biosciences, Franklin Lakes, NJ, USA), anti-CD4 PerCP (BD Biosciences), and anti-CD8 PE-Cy7 (BD Biosciences) diluted in PBS for 30 min at 4&#xb0;C. The cells were washed twice with PBS and&#xa0;fixed with BD Cytofix/Cytoperm&#x2122;, accordingly to manufacturer&#x2019;s instructions. Thereafter, the cells were washed twice with BD Perm/Wash&#x2122; buffer and stained with the monoclonal antibodies anti-IFN-&#x3b3; APC (BD Biosciences) and anti-Perforin PE (BioLegend) diluted in BD Perm/Wash&#x2122; buffer for 30 min at 4&#xb0;C. The cells were washed twice with BD Perm/Wash&#x2122; buffer and resuspended in PBS. The samples were acquired with a FACS Canto II (BD Biosciences) cytometer and analyzed with FlowJo 10 software (BD Biosciences).</p>
</sec>
<sec id="s2_9">
<title>Histological Analysis</title>
<p>Heart samples were fixed in a 10% buffered formalin solution, dehydrated in an increasing concentration of ethanol (Merck), and embedded in paraffin. The blocks were sectioned with a thickness of 5 &#x3bc;m and stained with hematoxylin-eosin (H&amp;E). The pathologist performed blinded histological analysis and provided a score for the intensity of myocarditis, as follows: (0) absence of myocarditis: absence or minimal focal inflammatory infiltrate; (1)&#xa0;mild myocarditis: mild, focal, or multifocal inflammatory infiltrate, with little cardiomyocyte aggression; (2) moderate myocarditis: clear inflammatory infiltrate, predominantly multifocal with occasional diffuse areas (coalescence), with multiple foci of cardiomyocyte aggression; and (3) intense myocarditis: exuberant inflammatory infiltrate, predominantly diffuse, with multiple foci of cardiomyocyte aggression.</p>
</sec>
<sec id="s2_10">
<title>Statistical Analysis</title>
<p>The results were analyzed using the Graph Pad Prism 8 software. We used Mann-Whitney <italic>U</italic> test for comparisons between 2 parameters and two-way ANOVA, Tukey&#x2019;s, and Bonferroni&#x2019;s tests for multiple comparisons. Pearson&#x2019;s correlation coefficient was used for correlation analysis.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>STING Deficiency Negatively Impacts Activation of IRF-Dependent Pathways and Cytokine Expression in Response to <italic>Trypanosoma cruzi</italic> Infection</title>
<p>Although previous data have suggested that a TBK-1/IRF3-dependent signaling pathway is essential for IFN-&#x3b2; induction in response to <italic>T. cruzi</italic> infection, the role of STING remained to be determined (<xref ref-type="bibr" rid="B45">45</xref>). To address this question, we used RAW264.7-Lucia&#x2122; ISG and RAW264.7-Lucia&#x2122; ISG-STING-KO macrophages, which are sufficient or deficient for STING expression, respectively, and designed to secrete luciferase into the culture medium in response to activation of IRF-dependent signaling pathways. We incubated these cells with live or heat-killed <italic>T. cruzi</italic> Y strain trypomastigotes for 16 h, removed residual parasites, and incubated for additional 24 h to collect supernatant and total RNA for evaluation of luciferase activity and gene expression (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). We observed that although infection of STING-KO macrophages promoted activation of IRF-dependent pathways, this activation was significantly lower than that observed for RAW264.7 ISG macrophages upon <italic>T. cruzi</italic> infection (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). On the other hand, no differences in activation of IRF-dependent pathways were found in heat-killed <italic>T. cruzi</italic>-exposed STING-KO or RAW264.7 ISG macrophages when compared with their respective controls (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). In line with our luciferase results, we observed significantly lower IFN-&#x3b2;, IL-6, and IL-12 gene expression in STING-KO-infected macrophages when compared with RAW264.7 ISG-infected macrophages, while no induction of these genes was observed in either STING-KO or RAW264.7 ISG macrophages exposed to heat-killed <italic>T. cruzi</italic> (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1C&#x2013;E</bold>
</xref>). Infection with <italic>T. cruzi</italic> resulted in similar induction of TNF-&#x3b1; gene expression in STING-KO and RAW264.7 ISG macrophages, but no significant response was observed upon exposure to heat-killed trypomastigotes (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure S1A</bold>
</xref>). We also evaluated NO production in response to infection and found no difference when comparing STING-KO and RAW264.7 ISG macrophages (<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure S2A</bold>
</xref>). Overall, our results indicate that STING deficiency negatively impacts activation of IRF-dependent pathways and cytokine expression in response to <italic>Trypanosoma cruzi</italic> infection, while heat-killed trypomastigotes failed to promote activation of RAW264.7 macrophages.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>STING deficiency negatively impacts activation of IRF-dependent pathways and cytokine expression in response to <italic>T. cruzi</italic> infection. <bold>(A)</bold> Experimental procedure. <bold>(B)</bold> IRF-dependent luciferase activity of STING-KO and RAW264.7 ISG macrophages infected or exposed to heat-killed <italic>T. cruzi</italic>. <bold>(C&#x2013;E)</bold> Real-time PCR analysis of IFN-&#x3b2;, IL-6, and IL-12 mRNA expression in STING-KO and RAW264.7 ISG macrophages infected or exposed to heat-killed <italic>T. cruzi</italic>. HPRT1 was used as housekeeping gene. Control, <italic>T. cruzi</italic> uninfected/unexposed STING-KO and RAW264.7 ISG macrophages; NS, no statistical significance. <bold>(B&#x2013;E)</bold> Two-way ANOVA and Tukey&#x2019;s multiple comparison test. Data are shown as mean &#xb1; SD. Experimental figure was created with <uri xlink:href="http://biorender.com">BioRender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-775346-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>
<italic>Trypanosoma cruzi</italic> DNA Induces STING-Dependent Cytokine Expression</title>
<p>DNA from adenovirus 5, herpes simplex virus, <italic>Listeria monocytogenes Plasmodium</italic> sp., and <italic>Leishmania donovani</italic> activates STING-dependent signaling in a variety of cells, indicating that STING signaling may have a role in immune responses to multiple pathogens (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>). Therefore, we hypothesized that STING would be required for cytokine induction in response to <italic>T. cruzi</italic> DNA. To test our hypothesis, we transfected RAW264.7-Lucia&#x2122; ISG and RAW264.7-Lucia&#x2122; ISG-STING-KO cells with <italic>T. cruzi</italic> Y strain DNA, collected supernatant and total RNA 24 h after transfection, and evaluated luciferase activity and gene expression (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). We found that STING was essential for DNA-mediated activation of IRF-dependent pathways, as STING-KO cells showed significantly lower luciferase activity upon transfection (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). As observed for infection, STING-KO cells had significantly lower IFN-&#x3b2;, IL-6, and IL-12 gene expression in response to <italic>T. cruzi</italic> DNA (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C&#x2013;E</bold>
</xref>). Although STING-KO and RAW264.7 ISG cells had similar TNF-&#x3b1; gene expression upon infection, we found that parasite DNA transfection resulted in increased TNF-&#x3b1; gene expression in RAW264.7 ISG cells when compared with nontransfected control, which was not observed in STING-KO cells (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure S1B</bold>
</xref>). To ensure our system was working properly, we transfected RAW264.7 ISG and STING-KO cells with poly IC (TLR3 ligand) and c-di-GMP (STING ligand). We observed that while STING-KO cells were responsive to poly IC, c-di-GMP elicited no luciferase activity or gene expression. In contrast to infection and parasite DNA, c-di-GMP failed to induce IL-6 and IL-12 gene expression while poly IC failed to induce IL-12 gene expression in RAW264.7 ISG cells (<xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Figures S3A&#x2013;D</bold>
</xref>). Taken together, these results indicate that <italic>T. cruzi</italic> DNA activates STING-dependent signaling.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>
<italic>Trypanosoma cruzi</italic> DNA activates STING-dependent signaling. <bold>(A)</bold> Experimental procedure. <bold>(B)</bold> IRF-dependent luciferase activity of nontransfected (NT) and <italic>T. cruzi</italic> DNA-transfected STING-KO and RAW264.7 ISG macrophages. <bold>(C&#x2013;E)</bold> Real-time PCR analysis of IFN-&#x3b2;, IL-6, and IL-12 mRNA expression in nontransfected (NT) and <italic>T. cruzi</italic> DNA-transfected STING-KO and RAW264.7 ISG macrophages. HPRT1 was used as housekeeping gene. NS, no statistical significance. <bold>(B&#x2013;E)</bold> Two-way ANOVA and Tukey&#x2019;s multiple comparison test. Data are shown as mean &#xb1; SD. Experimental figure was created with <uri xlink:href="http://biorender.com">BioRender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-775346-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>STING Signaling Increases Resistance to Acute <italic>T. cruzi</italic> Infection and Promotes Expression of Key Immunological Genes in the Heart of Infected Animals</title>
<p>Our <italic>in vitro</italic> results suggested that STING is required for induction of cytokines involved in <italic>T. cruzi</italic> immunity. Therefore, we hypothesized that STING-KO mice would have lower immune activation and would be less effective in controlling the parasite during acute infection. To test our hypothesis, we intraperitoneally infected C57BL6 and STING-KO mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>) and found that STING-KO mice had significantly higher parasitemia from days 5 to 8 after infection (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Real-time PCR analysis showed that both groups of animals had similar amounts of <italic>T. cruzi</italic> DNA in the heart on days 4 and 7 after infection (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). However, we observed significantly higher amounts of <italic>T. cruzi</italic> DNA in the hearts of STING-KO-infected animals at day 13 after infection (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>), indicating that STING-dependent signaling plays a role in parasite control.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>STING signaling increases resistance to <italic>T. cruzi</italic> infection. <bold>(A)</bold> Experimental procedure. <bold>(B)</bold> Parasitemia of STING-KO and C57BL6-infected mice. <bold>(C)</bold> Real-time PCR analysis of <italic>T. cruzi</italic> DNA in the hearts of STING-KO and C57BL6 mice 4, 7, and 13 days after infection. <bold>(D, E)</bold> Histological analysis of the hearts of STING-KO and C57BL6 mice 13 days after infection, &#xd7;200 magnification. NS, no statistical significance. <bold>(B, C)</bold> Two-way ANOVA and Bonferroni&#x2019;s multiple comparison test. <bold>(E)</bold> Two-way ANOVA and Tukey&#x2019;s multiple comparison test. <bold>(B, D)</bold> Data are shown as mean &#xb1; SD. <bold>(C)</bold> Data are shown as mean &#xb1; SEM. Experimental figure was created with <uri xlink:href="http://biorender.com">BioRender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-775346-g003.tif"/>
</fig>
<p>We performed heart histological analysis of STING-KO and C57BL6-infected animals and observed no difference in the magnitude of inflammatory infiltration 13 days after infection (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3D, E</bold>
</xref>
<bold>)</bold>. Real-time PCR analysis of the heart tissue at days 4, 7, and 13 after infection revealed a kinetic increase in the expression of genes related to immune control of the parasite in both groups of animals. Notably, IFN-&#x3b2; gene expression was significantly lower in the hearts of STING-KO mice at days 7 and 13 after infection when compared with C57BL6 mice (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). IL-12, CXCL9, IFN-&#x3b3;, and perforin gene expression was significantly lower in the hearts of STING-KO mice 13 days after infection (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4C&#x2013;F</bold>
</xref>). No significant difference in IL-6 gene expression was found in the hearts of STING-KO-infected mice when compared with C57BL6 mice (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>), while significantly lower TNF-&#x3b1; gene expression was observed in the hearts of STING-KO mice 13 days after infection (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure S1C</bold>
</xref>), indicating that STING deficiency negatively impacts the expression of key genes related to protection against acute <italic>T. cruzi</italic> infection.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>STING deficiency negatively impacts immune responses in the heart of <italic>T. cruzi</italic>-infected mice. <bold>(A&#x2013;F)</bold> Real-time PCR analysis of IFN-&#x3b2;, IL-6, IL-12, CXCL9, IFN-&#x3b3;, and PRF1 mRNA expression in the hearts of STING-KO and C57BL6 mice 4, 7, and 13 days after infection. <bold>(G&#x2013;L)</bold> Correlation analysis of IFN-&#x3b2;, IL-6, IL-12, CXCL9, IFN-&#x3b3;, and PRF1 mRNA expression with <italic>T. cruzi</italic> DNA in the hearts of STING-KO (blue circles) and C57BL6 (red circles) mice 13 days after infection. NS, no statistical significance. <bold>(A&#x2013;F)</bold> Two-way ANOVA and Bonferroni&#x2019;s multiple comparison test. <bold>(G&#x2013;L)</bold> Pearson&#x2019;s correlation. <bold>(A&#x2013;F)</bold> Data are shown as mean &#xb1; SEM.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-775346-g004.tif"/>
</fig>
<p>Given that all immunological genes evaluated in our study were previously shown to contribute to protection against acute <italic>T. cruzi</italic> infection, we performed correlation analysis to understand whether the magnitude of gene expression would be associated with parasite control. We found that IFN-&#x3b2;, IL-6, and IL-12 gene expression had no correlation with <italic>T. cruzi</italic> DNA in the heart at day 13 after infection (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4G&#x2013;I</bold>
</xref>). However, CXCL9, IFN-&#x3b3;, and perforin gene expression was inversely correlated with <italic>T. cruzi</italic> DNA (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4J&#x2013;L</bold>
</xref>). Moreover, we observed a positive correlation among CXCL9, IFN-&#x3b3;, and perforin gene expression in the heart of infected animals (<xref ref-type="supplementary-material" rid="SF4">
<bold>Supplementary Figures S4A&#x2013;C</bold>
</xref>), suggesting that CXCL9-mediated recruitment of IFN-&#x3b3; and perforin-expressing cells may have had a positive impact on parasite control at day 13 after infection.</p>
</sec>
<sec id="s3_4">
<title>STING Signaling Promotes Expression of Innate Cytokines and Generation of CD8<sup>+</sup> T Cells in the Spleen of Infected Animals</title>
<p>To have a more systemic view of the immune response to the parasite in the context of STING signaling, we evaluated the spleens of STING-KO- and C57BL6-infected mice at days 4, 7, and 13 after infection. We observed that IFN-&#x3b2;, IL-6 and IL-12 gene expression was higher at day 4 after infection and decreased overtime in both groups of animals (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A&#x2013;C</bold>
</xref>). Notably, STING-KO-infected mice had significantly lower IFN-&#x3b2; and IL-6 gene expression in the spleen at day 4 after infection when compared with C57BL6-infected mice (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>
<bold>)</bold>, indicating that STING-dependent signaling may play a role in early induction of key cytokines against <italic>T. cruzi</italic>. On the other hand, IL-12 gene expression (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>) and TNF-&#x3b1; gene expression were similar in the spleens of STING-KO- and C57BL6-infected mice in all time points (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure S1D</bold>
</xref>). We also evaluated NO production by splenocytes and found no significant differences between groups (<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure S2B</bold>
</xref>), suggesting the involvement of other signaling pathways in immunity to <italic>T. cruzi</italic>.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>STING deficiency negatively impacts innate cytokine expression and generation of CD8<sup>+</sup> T cells in response to <italic>T. cruzi</italic> infection. <bold>(A&#x2013;C)</bold> Real-time PCR analysis of IFN-&#x3b2;, IL-6, and IL-12 mRNA expression in the spleens of STING-KO and C57BL6 mice 4, 7, and 13 days after infection. <bold>(D)</bold> Intracellular flow cytometry analysis of IFN-&#x3b3; and perforin production by CD8<sup>+</sup> T cells. <bold>(E, F)</bold> Number (#) of IFN-&#x3b3;, perforin, and IFN-&#x3b3;/perforin producing-CD8<sup>+</sup> T cells in total splenocytes of uninfected mice, nonstimulated (NS) or stimulated with TSKB20 peptide 13 days after infection. <bold>(H&#x2013;J)</bold> Number (#) of IFN-&#x3b3;, perforin, and IFN-&#x3b3;/perforin-producing CD8<sup>+</sup> T cells in total splenocytes of <italic>T. cruzi</italic>-infected mice, nonstimulated (NS) or stimulated with TSKB20 peptide 13 days after infection. NS, no statistical significance. <bold>(A&#x2013;C)</bold> Two-way ANOVA and Bonferroni&#x2019;s multiple comparison test. <bold>(E&#x2013;J)</bold> Two-way ANOVA and Tukey&#x2019;s multiple comparison test. <bold>(A&#x2013;C)</bold> Data are shown as mean &#xb1; SEM. <bold>(E&#x2013;J)</bold> Data are shown as mean &#xb1; SD.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-775346-g005.tif"/>
</fig>
<p>To further exploit the role of STING signaling in <italic>T. cruzi</italic>-driven immunity, we performed flow cytometry using splenocytes to investigate IFN-&#x3b3; and perforin production by CD8<sup>+</sup> T cells against a <italic>T. cruzi</italic> H-2K<sup>b</sup>-restricted peptide named TSKB20 (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). As expected, we found very low numbers of splenic IFN-&#x3b3;, perforin, and IFN-&#x3b3;/perforin-producing CD8<sup>+</sup> T cells in uninfected animals (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5E&#x2013;G</bold>
</xref>). On the other hand, we observed significantly lower numbers of splenic TSKB20-specific IFN-&#x3b3; and IFN-&#x3b3;/perforin-producing CD8<sup>+</sup> T cells in STING-KO-infected mice when compared with C57BL6-infected mice (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5H, J</bold>
</xref>
<bold>)</bold>, while the numbers of splenic TSKB20-specific CD8<sup>+</sup> T cells producing only perforin were similar in both groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5I</bold>
</xref>). Collectively, our results indicate that STING signaling promotes expression of innate cytokines and generation of CD8<sup>+</sup> T cells against <italic>T. cruzi</italic>.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Innate and adaptive immune responses are required for controlling <italic>T. cruzi</italic> replication and disease establishment (<xref ref-type="bibr" rid="B54">54</xref>). Although TLR-dependent IFN-&#x3b2; production increase resistance to infection in mice (<xref ref-type="bibr" rid="B16">16</xref>), contrasting data have demonstrated that MyD88, TRIF, TLR-2-, TLR-3-, and TLR-4-deficient MEF, and bone marrow-derived macrophages (BMDM) still produce IFN-&#x3b2; in response to <italic>T. cruzi</italic>, while TBK-1 and IRF3 deficiency significantly impairs IFN-&#x3b2; production (<xref ref-type="bibr" rid="B45">45</xref>).</p>
<p>STING signaling, which is intimately related to TBK-1 and IRF3, has been studied in the context of immunity to many pathogens (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Formulations with STING ligand (c-di-AMP) as an adjuvant have been shown to increase immunogenicity of anti-<italic>T. cruzi</italic> vaccines (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). In addition, previous work has demonstrated that <italic>in vitro</italic> cGAS inhibition limits macrophage response to extracellular vesicles derived from <italic>T. cruzi</italic>-infected cells (<xref ref-type="bibr" rid="B44">44</xref>). However, the role of STING during <italic>in vitro</italic> and <italic>in vivo T. cruzi</italic> infection remained to be addressed.</p>
<p>Here, we showed that STING is not only required for&#xa0;expression of IFN-&#x3b2; in <italic>T. cruzi</italic>-infected RAW264.7 macrophages but also promotes IL-6 and IL-12 expression, which are involved in host resistance to infection (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). We demonstrated that activation of IRF-dependent signaling is negatively impacted by STING absence but may also rely on other pathways, as we still observed significantly higher luciferase activity in STING-KO-infected macrophages when compared with STING-KO-uninfected macrophages. In contrast to previous data demonstrating IFN-&#x3b2; expression by MEF exposed to dead trypomastigotes (<xref ref-type="bibr" rid="B45">45</xref>), we found no significant differences in cytokine expression or luciferase activity in either STING-KO or RAW264.7 ISG cells exposed&#xa0;to heat-killed trypomastigotes, indicating that live trypomastigotes are required for activation of IRF-dependent pathways and cytokine expression in RAW264.7 macrophages. Whether <italic>T. cruzi</italic> internalization through phagocytosis occurred (<xref ref-type="bibr" rid="B55">55</xref>), it was not sufficient to alter our parameters in STING-KO and RAW264.7 ISG cells.</p>
<p>Previous data have demonstrated that adenovirus 5, herpes simplex virus, <italic>Listeria monocytogenes</italic>, <italic>Plasmodium</italic> sp., and <italic>Leishmania donovani</italic> DNAs activate STING-dependent signaling in a variety of cells, such as human monocytes, STING-expressing HEK293 cells, MEF, and RAW264.7 ISG macrophages (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>). Our results bring additional support to these observations by demonstrating that <italic>T. cruzi</italic> DNA transfection triggers robust STING-mediated activation of IRF-dependent pathways and expression of IFN-&#x3b2;, IL-6, and IL-12 genes, reinforcing the role of STING signaling in intracellular DNA sensing and host defense against microbial infection (<xref ref-type="bibr" rid="B39">39</xref>).</p>
<p>In line with most infections in humans, we investigated <italic>T. cruzi</italic>-driven immune response and parasite control using a parasite inoculum that was not lethal in acute infection. Our results demonstrated that STING absence negatively impacted parasite control, as we observed significantly higher parasitemia in STING-KO mice from days 5 to 8 of infection. Although not statistically significant, we noticed an early difference in systemic infection control, with 60% less blood parasites in C57BL6 mice at day 4 after infection, indicating that innate immunity may have had a major impact on initial parasite infection. In fact, higher IFN-&#x3b2; and IL-6 gene expression in the spleens of C57BL6 mice at the same period corroborates our hypothesis. Although other studies regarding innate immunity have shown distinct intensity and kinetics in parasite control, late differences in parasitemia were more frequently observed (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>). In addition, we cannot exclude that parasite strain and inoculum may have contributed to our observations.</p>
<p>STING deficiency resulted in significantly higher heart parasitism at day 13 after infection, suggesting impairment of local immunity. Although we found no difference in the intensity of myocardial inflammatory infiltrate, the quality of the immune response may have been affected, as suggested by lower expression of genes related to immune protection against acute infection in the hearts of STING-KO mice. The kinetics of the local immune response may also have contributed to early parasite control, as STING-KO mice presented much less-efficient IFN-&#x3b2; response at day 7 after infection, which was when we detected parasite DNA for the first time in the heart of infected animals. Supporting our hypothesis, previous data have demonstrated early induction of type I IFN response against <italic>T. cruzi</italic> Y strain at the skin of infected mice (<xref ref-type="bibr" rid="B56">56</xref>).</p>
<p>CXCL9 chemokine gene expression, known to promote migration of effector T cells to infected tissues and protective immune response against <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="B57">57</xref>&#x2013;<xref ref-type="bibr" rid="B60">60</xref>), was found to be significantly lower in the hearts of STING-KO mice at day 13 after infection, as was IFN-&#x3b3; and perforin gene expression. In addition, our analysis demonstrated a positive correlation among these 3 genes, indicating that STING signaling may drive CXCL9-dependent infiltration of IFN-&#x3b3; and perforin-producing cells in the hearts of acutely infected animals. Although CD4<sup>+</sup> T cells have been demonstrated as an important source of IFN-&#x3b3; during infection (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>) and natural killer (NK) cells may also migrate in response to CXCL9 (<xref ref-type="bibr" rid="B63">63</xref>) and express IFN-&#x3b3; and perforin (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>), CD8<sup>+</sup> T cells are still the most predominant infiltrated population in the heart (<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>), leading to the hypothesis that CD8<sup>+</sup> T cells may have played a major role in ours findings. Nevertheless, further investigation will be necessary to demonstrate whether STING signaling modulates NK and CD4<sup>+</sup> T cells during infection.</p>
<p>Our flow cytometry analysis revealed a negative impact of STING deficiency on the numbers of splenic parasite-specific IFN-&#x3b3; and IFN-&#x3b3;/perforin-producing CD8<sup>+</sup> T cells at day 13 after infection, which may explain why we found lower IFN-&#x3b3; and perforin gene expression in the hearts of STING-KO-infected mice. In contrast to our data, TLR4-KO animals were shown to have preserved CD8<sup>+</sup> T cells while having impaired innate immunity against <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="B8">8</xref>), indicating a broader function of STING signaling in immune responses to the parasite. While generation of <italic>T. cruzi</italic>-specific CD8<sup>+</sup> T cells has been shown to be unaffected by the absence of type I interferon signaling (<xref ref-type="bibr" rid="B68">68</xref>), we believe that impairment in the production of IFN-&#x3b2;, IL-6, and IL-12 against the parasite in STING-KO mice may have had a major impact on the CD8<sup>+</sup> T cells. In fact, these three cytokines have been shown to promote CD8<sup>+</sup> T cell activation, proliferation, and survival (<xref ref-type="bibr" rid="B69">69</xref>&#x2013;<xref ref-type="bibr" rid="B73">73</xref>), supporting our hypothesis.</p>
<p>Perforin-producing CD8<sup>+</sup> T cells have a contradictory role in acute and chronic <italic>T. cruzi</italic> infection, being related to myocarditis and heart damage in chronically infected mice (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). In contrast, IFN-&#x3b3;-producing CD8<sup>+</sup> T cells have been indicated as protective in both experimental models and patients, although a dysregulated IFN-&#x3b3; response may be suggested as detrimental in chronic Chagas disease cardiomyopathy (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B74">74</xref>). Here, we showed an inverse correlation between parasite DNA and the expression of CXCL9, IFN-&#x3b3; and perforin in the hearts of infected animals, reinforcing a protective role for these genes in acute infection. Moreover, we found a more prominent impairment in parasite-specific IFN-&#x3b3;-producing CD8<sup>+</sup> T cells in STING-KO mice, suggesting that STING signaling may be responsible to promote a more effective CD8<sup>+</sup> T cell-mediated immune response against <italic>T. cruzi</italic>. Therefore, we believe our results bring an important contribution to the field of imunoparasitology by unveiling new molecular mechanisms underlying immunity against this remarkable pathogen.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Material</bold>
</xref> Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Ethics Committee on the Use of Animals (CEUA) of the Faculty of Medicine, University of Sao Paulo (FMUSP).</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author Contributions</title>
<p>RV and RA contributed to conceptualization, formal analysis, methodology, investigation, writing of original draft, and manuscript revision. MN, IN, JV, and LB contributed to methodology, investigation, and formal analysis. GB contributed with resources and formal analysis. NC, JK, and EC contributed with resources and manuscript revision. EC contributed to funding acquisition. RA contributed to study supervision. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by grants from Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico to ECN (CNPq, <uri xlink:href="http://www.cnpq.br">www.cnpq.br</uri>, grant #465434/2014-2) and Funda&#xe7;&#xe3;o de Amapro &#xe0; Pesquisa do Estado de S&#xe3;o Paulo to ECN (Fapesp, <uri xlink:href="http://www.fapesp.br">www.fapesp.br</uri>, grants #2014/50890-5 and #2016/152090).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Luis Roberto Mundel and Edilberto Post&#xf3;l for assistance at the animal facility. We also thank Andreia Kuramoto Takara for technical assistance.</p>
</ack>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2021.775346/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2021.775346/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.pdf" id="SF1" mimetype="application/pdf">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>STING deficiency has variable impact on TNF-&#x3b1; response to <italic>T. cruzi</italic>. <bold>(A)</bold> Real-time PCR analysis of TNF-&#x3b1; mRNA expression in STING-KO and RAW264.7 ISG macrophages infected or exposed to heat-killed <italic>T. cruzi</italic>. <bold>(B)</bold> Real-time PCR analysis of TNF-&#x3b1; mRNA expression in non-transfected (NT) and <italic>T. cruzi</italic> DNA-transfected STING-KO and RAW264.7 ISG macrophages. <bold>(C, D)</bold> Real-time PCR analysis of TNF-&#x3b1; mRNA expression in the hearts and spleens of STING-KO and C57BL6 mice 4, 7 and 13 days after infection, respectively. HPRT1 was used as housekeeping gene. NS, no statistical significance. <bold>(A, B)</bold> Two-way ANOVA and Tukey&#x2019;s multiple comparison test. <bold>(C, D)</bold> Two-way ANOVA and Bonferroni&#x2019;s multiple comparison test. <bold>(A, B)</bold> Data are shown as mean &#xb1; S.D. <bold>(C, D)</bold> Data are shown as mean &#xb1; S.E.M.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_2.pdf" id="SF2" mimetype="application/pdf">
<label>Supplementary Figure&#xa0;2</label>
<caption>
<p>STING deficiency has no impact on nitric oxide production against <italic>T. cruzi</italic>. <bold>(A)</bold> Nitrite detection in the supernatant of uninfected and infected STING-KO and RAW264.7 ISG macrophages 48h after infection. <bold>(B)</bold> Nitrite detection in the supernatant of splenocytes from STING-KO and C57BL6 mice at days 4, 7 and 13 after infection, incubated for 48h. NS, no statistical significance. <bold>(A)</bold> Two-way ANOVA and Tukey&#x2019;s multiple comparison test. <bold>(B)</bold> Two-way ANOVA and Bonferroni&#x2019;s multiple comparison test. <bold>(A)</bold> Data are shown as mean &#xb1; S.D. <bold>(B)</bold> Data are shown as mean &#xb1; S.E.M.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_3.pdf" id="SF3" mimetype="application/pdf">
<label>Supplementary Figure&#xa0;3</label>
<caption>
<p>STING-KO macrophages are responsive to poly IC but not to c-di-GMP transfection. <bold>(A)</bold> IRF-dependent luciferase activity of non-transfected (NT) and transfected STING-KO and RAW264.7 ISG macrophages. <bold>(B&#x2013;D)</bold> Real-time PCR analysis of IFN-&#x3b2;, IL-6 and IL-12 mRNA expression in non-transfected (NT) and transfected STING-KO and RAW264.7 ISG macrophages. HPRT1 was used as housekeeping gene. NS = no statistical significance. <bold>(A&#x2013;D)</bold> Two-way ANOVA and Tukey&#x2019;s multiple comparison test. <bold>(A&#x2013;D)</bold> Data are shown as mean &#xb1; S.D.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_4.pdf" id="SF4" mimetype="application/pdf">
<label>Supplementary Figure&#xa0;4</label>
<caption>
<p>CXCL9, IFN-&#x3b3; and perforin gene expression positively correlates in the hearts of infected animals. <bold>(A&#x2013;C)</bold> Pearson&#x2019;s correlation analysis of CXCL9, IFN-&#x3b3; and PRF1 mRNA expression in the hearts of STING-KO (blue circles) and C57BL6 (red circles) mice 13 days after infection.</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rassi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Marin-Neto</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Chagas Disease</article-title>. <source>Lancet</source> (<year>2010</year>) <volume>375</volume>(<issue>9723</issue>):<page-range>1388&#x2013;402</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(10)60061-x</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chevillard</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nunes</surname> <given-names>JPS</given-names>
</name>
<name>
<surname>Frade</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Pandey</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Nascimento</surname> <given-names>MS</given-names>
</name>
<etal/>
</person-group>. <article-title>Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma Cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>2791</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02791</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cristov&#xe3;o-Silva</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Brelaz-de-Castro</surname> <given-names>MCA</given-names>
</name>
<name>
<surname>Hernandes</surname> <given-names>MZ</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>VRA</given-names>
</name>
</person-group>. <article-title>Chagas Disease: Immunology of the Disease at a Glance</article-title>. <source>Cytokine Growth Factor Rev</source> (<year>2021</year>) <volume>62</volume>:<fpage>15</fpage>&#x2013;<lpage>22</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cytogfr.2021.10.001</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campos</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>IC</given-names>
</name>
<name>
<surname>Takeuchi</surname> <given-names>O</given-names>
</name>
<name>
<surname>Akira</surname> <given-names>S</given-names>
</name>
<name>
<surname>Valente</surname> <given-names>EP</given-names>
</name>
<name>
<surname>Procopio</surname> <given-names>DO</given-names>
</name>
<etal/>
</person-group>. <article-title>Activation of Toll-Like Receptor-2 by Glycosylphosphatidylinositol Anchors From a Protozoan Parasite</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>167</volume>(<issue>1</issue>):<page-range>416&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.167.1.416</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Peixoto</surname> <given-names>JR</given-names>
</name>
<name>
<surname>de Arruda</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Campos</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Golenbock</surname> <given-names>DT</given-names>
</name>
<etal/>
</person-group>. <article-title>Expression of Functional TLR4 Confers Proinflammatory Responsiveness to Trypanosama Cruzi Glycoinositolphospholipids and Higher Resistance to Infection With T-Cruzi</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>(<issue>9</issue>):<page-range>5688&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.173.9.5688</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bafica</surname> <given-names>A</given-names>
</name>
<name>
<surname>Santiago</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Goldszmid</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ropert</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Sher</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Cutting Edge: TLR9 and TLR2 Signaling Together Account for MyD88-Dependent Control of Parasitemia in Trypanosoma Cruzi Infection</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>(<issue>6</issue>):<page-range>3515&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.177.6.3515</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campos</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Closel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Valente</surname> <given-names>EP</given-names>
</name>
<name>
<surname>Cardoso</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Akira</surname> <given-names>S</given-names>
</name>
<name>
<surname>Alvarez-Leite</surname> <given-names>JI</given-names>
</name>
<etal/>
</person-group>. <article-title>Impaired Production of Proinflammatory Cytokines and Host Resistance to Acute Infection With Trypanosoma Cruzi in Mice Lacking Functional Myeloid Differentiation Factor 88</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>172</volume>(<issue>3</issue>):<page-range>1711&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.172.3.1711</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname> <given-names>AC</given-names>
</name>
<name>
<surname>de Alencar</surname> <given-names>BC</given-names>
</name>
<name>
<surname>Tzelepis</surname> <given-names>F</given-names>
</name>
<name>
<surname>Klezewsky</surname> <given-names>W</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>RN</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>FS</given-names>
</name>
<etal/>
</person-group>. <article-title>Impaired Innate Immunity in Tlr4(-/-) Mice But Preserved CD8(+) T Cell Responses Against Trypanosoma Cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-Deficient Mice</article-title>. <source>PloS Pathog</source> (<year>2010</year>) <volume>6</volume>(<issue>4</issue>):<fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1000870</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname> <given-names>GK</given-names>
</name>
<name>
<surname>Gutierrez</surname> <given-names>FRS</given-names>
</name>
<name>
<surname>Guedes</surname> <given-names>PMM</given-names>
</name>
<name>
<surname>Horta</surname> <given-names>CV</given-names>
</name>
<name>
<surname>Cunha</surname> <given-names>LD</given-names>
</name>
<name>
<surname>Mineo</surname> <given-names>TWP</given-names>
</name>
<etal/>
</person-group>. <article-title>Cutting Edge: Nucleotide-Binding Oligomerization Domain 1-Dependent Responses Account for Murine Resistance Against Trypanosoma Cruzi Infection</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>(<issue>3</issue>):<page-range>1148&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0902254</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goncalves</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Matteucci</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Buzzo</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Miollo</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Ferrante</surname> <given-names>D</given-names>
</name>
<name>
<surname>Torrecilhas</surname> <given-names>AC</given-names>
</name>
<etal/>
</person-group>. <article-title>NLRP3 Controls Trypanosoma Cruzi Infection Through a Caspase-1-Dependent IL-1r-Independent NO Production</article-title>. <source>PloS Neglect Trop Dis</source> (<year>2013</year>) <volume>7</volume>(<issue>10</issue>):<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0002469</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerban</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Stempin</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Volpini</surname> <given-names>X</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>EAC</given-names>
</name>
<name>
<surname>Gea</surname> <given-names>S</given-names>
</name>
<name>
<surname>Motran</surname> <given-names>CC</given-names>
</name>
</person-group>. <article-title>Signaling Pathways That Regulate Trypanosoma Cruzi Infection and Immune Response</article-title>. <source>Biochim Et Biophys Acta-Mol Basis Dis</source> (<year>2020</year>) <volume>1866</volume>(<issue>5</issue>):<volume>18</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2020.165707</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>WD</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Interleukin-6 Is Required for Parasite Specific Response and Host Resistance to Trypanosoma Cruzi</article-title>. <source>Int J Parasitol</source> (<year>2002</year>) <volume>32</volume>(<issue>2</issue>):<page-range>167&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0020-7519(01)00322-8</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aliberti</surname> <given-names>JCS</given-names>
</name>
<name>
<surname>Cardoso</surname> <given-names>MAG</given-names>
</name>
<name>
<surname>Martins</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Vieira</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Interleukin-12 Mediates Resistance to Trypanosoma Cruzi in Mice and Is Produced by Murine Macrophages in Response to Live Trypomastigotes</article-title>. <source>Infect Immun</source> (<year>1996</year>) <volume>64</volume>(<issue>6</issue>):<page-range>1961&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1128/iai.64.6.1961-1967.1996</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graefe</surname> <given-names>SEB</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gaworski</surname> <given-names>I</given-names>
</name>
<name>
<surname>Klauenberg</surname> <given-names>U</given-names>
</name>
<name>
<surname>Steeg</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fleischer</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Interleukin-12 But Not Interleukin-18 Is Required for Immunity to Trypanosoma Cruzi in Mice</article-title>. <source>Microbes Infect</source> (<year>2003</year>) <volume>5</volume>(<issue>10</issue>):<page-range>833&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1286-4579(03)00176-x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahamsohn</surname> <given-names>IA</given-names>
</name>
<name>
<surname>Coffman</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Trypanosoma Cruzi: IL-10, TNF, IFN-Gamma, and IL-12 Regulate Innate and Acquired Immunity to Infection</article-title>. <source>Exp Parasitol</source> (<year>1996</year>) <volume>84</volume>(<issue>2</issue>):<page-range>231&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/expr.1996.0109</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koga</surname> <given-names>R</given-names>
</name>
<name>
<surname>Hamano</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kuwata</surname> <given-names>H</given-names>
</name>
<name>
<surname>Atarashi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ogawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hisaeda</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>TLR-Dependent Induction of IFN-Beta Mediates Host Defense Against Trypanosoma Cruzi</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>(<issue>10</issue>):<page-range>7059&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.177.10.7059</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname> <given-names>VMA</given-names>
</name>
<name>
<surname>Torres</surname> <given-names>KCL</given-names>
</name>
<name>
<surname>Mendonca</surname> <given-names>RZ</given-names>
</name>
<name>
<surname>Gresser</surname> <given-names>I</given-names>
</name>
<name>
<surname>Gollob</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Abrahamsohn</surname> <given-names>IA</given-names>
</name>
</person-group>. <article-title>Type I IFNs Stimulate Nitric Oxide Production and Resistance to Trypanosoma Cruzi Infection</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>(<issue>5</issue>):<page-range>3193&#x2013;200</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.177.5.3193</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tarleton</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Antigen-Specific Th1 But Not Th2 Cells Provide Protection From Lethal Trypanosoma Cruzi Infection in Mice</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>166</volume>(<issue>7</issue>):<page-range>4596&#x2013;603</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.166.7.4596</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoft</surname> <given-names>DF</given-names>
</name>
<name>
<surname>Schnapp</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Eickhoff</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Roodman</surname> <given-names>ST</given-names>
</name>
</person-group>. <article-title>Involvement of CD4(+) Th1 Cells in Systemic Immunity Protective Against Primary and Secondary Challenges With Trypanosoma Cruzi</article-title>. <source>Infect Immun</source> (<year>2000</year>) <volume>68</volume>(<issue>1</issue>):<fpage>197</fpage>&#x2013;<lpage>204</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.68.1.197-204.2000</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryan</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Guyach</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Norris</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>Specific Humoral Immunity Versus Polyclonal B Cell Activation in Trypanosoma Cruzi Infection of Susceptible and Resistant Mice</article-title>. <source>PloS Neglect Trop Dis</source> (<year>2010</year>) <volume>4</volume>(<issue>7</issue>):<fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0000733</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarleton</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Depletion of CD8+ T-Cells Increases Susceptibility and Reverses Vaccine-Induced Immunity in Mice Infected with Trypanosoma-Cruzi</article-title>. <source>J&#xa0;Immunol</source> (<year>1990</year>) <volume>144</volume>(<issue>2</issue>):<page-range>717&#x2013;24</page-range>.</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarleton</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Koller</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Latour</surname> <given-names>A</given-names>
</name>
<name>
<surname>Postan</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Susceptibility of Beta-2-Microglobulin-Deficient Mice to Trypanosoma-Cruzi Infection</article-title>. <source>Nature</source> (<year>1992</year>) <volume>356</volume>(<issue>6367</issue>):<page-range>338&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/356338a0</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname> <given-names>EVA</given-names>
</name>
<name>
<surname>Furlan</surname> <given-names>CLA</given-names>
</name>
<name>
<surname>Vernengo</surname> <given-names>FF</given-names>
</name>
<name>
<surname>Montes</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Gruppi</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Understanding CD8(+) T Cell Immunity to Trypanosoma Cruzi and How to Improve It</article-title>. <source>Trends Parasitol</source> (<year>2019</year>) <volume>35</volume>(<issue>11</issue>):<fpage>899</fpage>&#x2013;<lpage>917</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pt.2019.08.006</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nickell</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Trypanosoma Cruzi: Roles for Perforin-Dependent and Perforin-Independent Immune Mechanisms in Acute Resistance</article-title>. <source>Exp Parasitol</source> (<year>2000</year>) <volume>94</volume>(<issue>4</issue>):<page-range>207&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/expr.2000.4498</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverio</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>IR</given-names>
</name>
<name>
<surname>Cipitelli</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Vinagre</surname> <given-names>NF</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>RT</given-names>
</name>
<etal/>
</person-group>. <article-title>CD8(+) T-Cells Expressing Interferon Gamma or Perforin Play Antagonistic Roles in Heart Injury in Experimental Trypanosoma Cruzi-Elicited Cardiomyopathy</article-title>. <source>PloS Pathog</source> (<year>2012</year>) <volume>8</volume>(<issue>4</issue>):<fpage>1</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1002645</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michailowsky</surname> <given-names>V</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Rocha</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Vieira</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>Lannes-Vieira</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>RT</given-names>
</name>
</person-group>. <article-title>Pivotal Role of Interleukin-12 and Interferon-Gamma Axis in Controlling Tissue Parasitism and Inflammation in the Heart and Central Nervous System During Trypanosoma Cruzi Infection</article-title>. <source>Am J Pathol</source> (<year>2001</year>) <volume>159</volume>(<issue>5</issue>):<page-range>1723&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0002-9440(10)63019-2</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laucella</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Postan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hubby Fralish</surname> <given-names>B</given-names>
</name>
<name>
<surname>Albareda</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>MG</given-names>
</name>
<etal/>
</person-group>. <article-title>Frequency of Interferon- Gamma -Producing T Cells Specific for Trypanosoma Cruzi Inversely Correlates With Disease Severity in Chronic Human Chagas Disease</article-title>. <source>J Infect Dis</source> (<year>2004</year>) <volume>189</volume>(<issue>5</issue>):<page-range>909&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/381682</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albareda</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Laucella</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Armenti</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Bertochi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tarleton</surname> <given-names>RL</given-names>
</name>
<etal/>
</person-group>. <article-title>Trypanosoma Cruzi Modulates the Profile of Memory CD8(+) T Cells in Chronic Chagas&#x2019; Disease Patients</article-title>. <source>Int Immunol</source> (<year>2006</year>) <volume>18</volume>(<issue>3</issue>):<page-range>465&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/intimm/dxh387</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takaoka</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Yanai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Negishi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ban</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>DAI (DLM-1/ZBP1) Is a Cytosolic DNA Sensor and an Activator of Innate Immune Response</article-title>. <source>Nature</source> (<year>2007</year>) <volume>448</volume>(<issue>7152</issue>):<page-range>501&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature06013</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>P</given-names>
</name>
<name>
<surname>An</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Rui</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>The Cytosolic Nucleic Acid Sensor LRRFIP1 Mediates the Production of Type I Interferon <italic>via</italic> a Beta-Catenin-Dependent Pathway</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>(<issue>6</issue>):<page-range>487&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1876</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>ZQ</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>T</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YJ</given-names>
</name>
</person-group>. <article-title>The Helicase DDX41 Senses Intracellular DNA Mediated by the Adaptor STING in Dendritic Cells</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>(<issue>10</issue>):<fpage>959</fpage>&#x2013;<lpage>U62</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.2091</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unterholzner</surname> <given-names>L</given-names>
</name>
<name>
<surname>Keating</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Baran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Horan</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Jensen</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>IFI16 Is an Innate Immune Sensor for Intracellular DNA</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>(<issue>11</issue>):<fpage>997</fpage>&#x2013;<lpage>1004</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1932</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Du</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>ZJ</given-names>
</name>
</person-group>. <article-title>Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>(<issue>6121</issue>):<page-range>786&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1232458</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saitoh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Fujita</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hayashi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Takahara</surname> <given-names>K</given-names>
</name>
<name>
<surname>Satoh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Atg9a Controls dsDNA-Driven Dynamic Translocation of STING and the Innate Immune Response</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2009</year>) <volume>106</volume>(<issue>49</issue>):<page-range>20842&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0911267106</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>ZJJ</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>XC</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>XW</given-names>
</name>
</person-group>. <article-title>Cryo-EM Structures of STING Reveal Its Mechanism of Activation by Cyclic GMP-AMP</article-title>. <source>Nature</source> (<year>2019</year>) <volume>567</volume>(<issue>7748</issue>):<page-range>389</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-019-0998-5</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>ZJ</given-names>
</name>
</person-group>. <article-title>STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway</article-title>. <source>Sci Signal</source> (<year>2012</year>) <volume>5</volume>(<issue>214</issue>):<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/scisignal.2002521</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>QF</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>MZ</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>PF</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>XY</given-names>
</name>
<etal/>
</person-group>. <article-title>NEMO-IKK Beta Are Essential for IRF3 and NF-Kappa B Activation in the cGAS-STING Pathway</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>199</volume>(<issue>9</issue>):<page-range>3222&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1700699</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abe</surname> <given-names>T</given-names>
</name>
<name>
<surname>Barber</surname> <given-names>GN</given-names>
</name>
</person-group>. <article-title>Cytosolic-DNA-Mediated, STING-Dependent Proinflammatory Gene Induction Necessitates Canonical NF-Kappa B Activation Through TBK1</article-title>. <source>J Virol</source> (<year>2014</year>) <volume>88</volume>(<issue>10</issue>):<page-range>5328&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jvi.00037-14</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname> <given-names>J</given-names>
</name>
<name>
<surname>Barber</surname> <given-names>GN</given-names>
</name>
</person-group>. <article-title>STING Signaling and Host Defense Against Microbial Infection</article-title>. <source>Exp Mol Med</source> (<year>2019</year>) <volume>51</volume>(<issue>12</issue>):<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-019-0333-0</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>STING or Sting: cGAS-STING-Mediated Immune Response to Protozoan Parasites</article-title>. <source>Trends Parasitol</source> (<year>2020</year>) <volume>36</volume>(<issue>9</issue>):<page-range>773&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pt.2020.07.001</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>YY</given-names>
</name>
<name>
<surname>An</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Qiao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Li</surname> <given-names>XB</given-names>
</name>
</person-group>. <article-title>STING: A Master Regulator in the Cancer-Immunity Cycle</article-title>. <source>Mol Cancer</source> (<year>2019</year>) <volume>18</volume>(<issue>1</issue>):<fpage>2</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12943-019-1087-y</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alberti</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Bivona</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Cerny</surname> <given-names>N</given-names>
</name>
<name>
<surname>Schulze</surname> <given-names>K</given-names>
</name>
<name>
<surname>Weissmann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ebensen</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Engineered Trivalent Immunogen Adjuvanted With a STING Agonist Confers Protection Against Trypanosoma Cruzi Infection</article-title>. <source>NPJ Vaccines</source> (<year>2017</year>) <volume>2</volume>:<fpage>2</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41541-017-0010-z</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matos</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Cazorla</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Schulze</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ebensen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Guzm&#xe1;n</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Malchiodi</surname> <given-names>EL</given-names>
</name>
</person-group>. <article-title>Immunization With Tc52 or iIs Amino Terminal Domain Adjuvanted With C-Di-AMP Induces Th17+Th1 Specific Immune Responses and Confers Protection Against Trypanosoma Cruzi</article-title>. <source>PloS Negl Trop Dis</source> (<year>2017</year>) <volume>11</volume>(<issue>2</issue>):<fpage>e0005300</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0005300</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhuri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Garg</surname> <given-names>NJ</given-names>
</name>
</person-group>. <article-title>PARP1-cGAS-NF-Kappa B Pathway of Proinflammatory Macrophage Activation by Extracellular Vesicles Released During Trypanosoma Cruzi Infection and Chagas Disease</article-title>. <source>PloS Pathog</source> (<year>2020</year>) <volume>16</volume>(<issue>4</issue>):<fpage>1</fpage>&#x2013;<lpage>27</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1008474</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chessler</surname> <given-names>ADC</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>LRP</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Fitzgerald</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Burleiph</surname> <given-names>BA</given-names>
</name>
</person-group>. <article-title>A Novel IFN Regulatory Factor 3-Dependent Pathway Activated by Trypanosomes Triggers IFN-Beta in Macrophages and Fibroblasts</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>(<issue>11</issue>):<page-range>7917&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.181.11.7917</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishikawa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Barber</surname> <given-names>GN</given-names>
</name>
</person-group>. <article-title>STING Regulates Intracellular DNA-Mediated, Type I Interferon-Dependent Innate Immunity</article-title>. <source>Nature</source> (<year>2009</year>) <volume>461</volume>(<issue>7265</issue>):<fpage>788</fpage>&#x2013;<lpage>U40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature08476</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brener</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Therapeutic Activity and Criterion of Cure on Mice Experimentally Infected With Trypanosoma Cruzi</article-title>. <source>Rev Inst Med Trop Sao Paulo</source> (<year>1962</year>) <volume>4</volume>:<page-range>389&#x2013;96</page-range>.</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piron</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fisa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Casamitjana</surname> <given-names>N</given-names>
</name>
<name>
<surname>L&#xf3;pez-Chejade</surname> <given-names>P</given-names>
</name>
<name>
<surname>Puig</surname> <given-names>L</given-names>
</name>
<name>
<surname>Verg&#xe9;s</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Development of a Real-Time PCR Assay for Trypanosoma Cruzi Detection in Blood Samples</article-title>. <source>Acta Trop</source> (<year>2007</year>) <volume>103</volume>(<issue>3</issue>):<fpage>195</fpage>&#x2013;<lpage>200</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actatropica.2007.05.019</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>DeOliveira</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Kalantari</surname> <given-names>P</given-names>
</name>
<name>
<surname>Parroche</surname> <given-names>P</given-names>
</name>
<name>
<surname>Goutagny</surname> <given-names>N</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>ZZ</given-names>
</name>
<etal/>
</person-group>. <article-title>Innate Immune Recognition of an AT-Rich Stem-Loop DNA Motif in the Plasmodium Falciparum Genome</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>35</volume>(<issue>2</issue>):<fpage>194</fpage>&#x2013;<lpage>207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.016</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallego-Marin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Schrum</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>WA</given-names>
</name>
<name>
<surname>Shaffer</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Giraldo</surname> <given-names>LF</given-names>
</name>
<name>
<surname>Lasso</surname> <given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>Cyclic GMP-AMP Synthase Is the Cytosolic Sensor of Plasmodium Falciparum Genomic DNA and Activates Type I IFN in Malaria</article-title>. <source>J Immunol</source> (<year>2018</year>) <volume>200</volume>(<issue>2</issue>):<page-range>768&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1701048</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mandal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Abhishek</surname> <given-names>K</given-names>
</name>
<name>
<surname>Verma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Das</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Nucleic Acid Sensing Activates the Innate Cytosolic Surveillance Pathway and Promotes Parasite Survival in Visceral Leishmaniasis</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>:<fpage>1</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-45800-0</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>BW</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>XL</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-Malaria Immunity and Host Mortality</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>45</volume>(<issue>5</issue>):<page-range>1093&#x2013;107</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.10.001</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Prabakaran</surname> <given-names>T</given-names>
</name>
<name>
<surname>Laustsen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jorgensen</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Rahbaek</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Jensen</surname> <given-names>SB</given-names>
</name>
<etal/>
</person-group>. <article-title>Listeria Monocytogenes Induces IFN Beta Expression Through an IFI16-, cGAS- and STING-Dependent Pathway</article-title>. <source>EMBO J</source> (<year>2014</year>) <volume>33</volume>(<issue>15</issue>):<page-range>1654&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embj.201488029</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acevedo</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Girard</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Gomez</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1929</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01929</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maganto-Garcia</surname> <given-names>E</given-names>
</name>
<name>
<surname>Punzon</surname> <given-names>C</given-names>
</name>
<name>
<surname>Terhorst</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fresno</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Rab5 Activation by Toll-Like Receptor 2 Is Required for Trypanosoma Cruzi Internalization and Replication in Macrophages</article-title>. <source>Traffic</source> (<year>2008</year>) <volume>9</volume>(<issue>8</issue>):<page-range>1299&#x2013;315</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0854.2008.00760.x</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chessler</surname> <given-names>ADC</given-names>
</name>
<name>
<surname>Unnikrishnan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bei</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Daily</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Burleigh</surname> <given-names>BA</given-names>
</name>
</person-group>. <article-title>Trypanosoma Cruzi Triggers an Early Type I IFN Response <italic>In Vivo</italic> at the Site of Intradermal Infection</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>(<issue>4</issue>):<page-range>2288&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0800621</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardison</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Wrightsman</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Carpenter</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Lane</surname> <given-names>TE</given-names>
</name>
<name>
<surname>Manning</surname> <given-names>JE</given-names>
</name>
</person-group>. <article-title>The Chemokines CXCL9 and CXCL10 Promote a Protective Immune Response But Do Not Contribute to Cardiac Inflammation Following Infection With Trypanosoma Cruzi</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>(<issue>1</issue>):<page-range>125&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.74.1.125-134.2006</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname> <given-names>CP</given-names>
</name>
<name>
<surname>Cariste</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Moraschi</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Zanetti</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Han</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>DA</given-names>
</name>
<etal/>
</person-group>. <article-title>CXCR3 Chemokine Receptor Guides Trypanosoma Cruzi-Specific T-Cells Triggered by DNA/adenovirus ASP2 Vaccine to Heart Tissue After Challenge</article-title>. <source>PloS Neglect Trop Dis</source> (<year>2019</year>) <volume>13</volume>(<issue>7</issue>):<fpage>1</fpage>&#x2013;<lpage>27</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0007597</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>RT</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Chemokines, Inflammation and Trypanosoma Cruzi Infection</article-title>. <source>Trends Parasitol</source> (<year>2002</year>) <volume>18</volume>(<issue>6</issue>):<page-range>262&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1471-4922(02)02283-3</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogueira</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>RHB</given-names>
</name>
<name>
<surname>Ianni</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Fiorelli</surname> <given-names>AI</given-names>
</name>
<name>
<surname>Mairena</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Benvenuti</surname> <given-names>LA</given-names>
</name>
<etal/>
</person-group>. <article-title>Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10</article-title>. <source>PloS Neglect Trop Dis</source> (<year>2012</year>) <volume>6</volume>(<issue>10</issue>):<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0001867</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanoja</surname> <given-names>C</given-names>
</name>
<name>
<surname>Carbajosa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fresno</surname> <given-names>M</given-names>
</name>
<name>
<surname>Girones</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Analysis of the Dynamics of Infiltrating CD4(+) T Cell Subsets in the Heart During Experimental Trypanosoma Cruzi Infection</article-title>. <source>PloS One</source> (<year>2013</year>) <volume>8</volume>(<issue>6</issue>):<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0065820</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albareda</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Olivera</surname> <given-names>GC</given-names>
</name>
<name>
<surname>Laucella</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Lococo</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Chronic Human Infection With Trypanosoma Cruzi Drives CD4(+) T Cells to Immune Senescence</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>(<issue>6</issue>):<page-range>4103&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0900852</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thapa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Welner</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Pelayo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Carr</surname> <given-names>DJJ</given-names>
</name>
</person-group>. <article-title>CXCL9 and CXCL10 Expression Are Critical for Control of Genital Herpes Simplex Virus Type 2 Infection Through Mobilization of HSV-Specific CTL and NK Cells to the Nervous System</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>(<issue>2</issue>):<page-range>1098&#x2013;106</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.180.2.1098</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieke</surname> <given-names>T</given-names>
</name>
<name>
<surname>Graefe</surname> <given-names>SEB</given-names>
</name>
<name>
<surname>Klauenberg</surname> <given-names>U</given-names>
</name>
<name>
<surname>Fleischer</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>NK Cells Contribute to the Control of Trypanosoma Cruzi Infection by Killing Free Parasites by Perforin-Independent Mechanisms</article-title>. <source>Infect Immun</source> (<year>2004</year>) <volume>72</volume>(<issue>12</issue>):<page-range>6817&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.72.12.6817-6825.2004</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardillo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Voltarelli</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Reed</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Regulation of Trypanosoma Cruzi Infection in Mice by Gamma Interferon and Interleukin 10: Role of NK Cells</article-title>. <source>Infect Immun</source> (<year>1996</year>) <volume>64</volume>(<issue>1</issue>):<page-range>128&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.64.1.128-134.1996</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>dos Santos</surname> <given-names>PVA</given-names>
</name>
<name>
<surname>Roffe</surname> <given-names>E</given-names>
</name>
<name>
<surname>Santiago</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Torres</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Marino</surname> <given-names>A</given-names>
</name>
<name>
<surname>Paiva</surname> <given-names>CN</given-names>
</name>
<etal/>
</person-group>. <article-title>Prevalence of CD8(+)alpha Beta T Cells in Trypanosoma Cruzi-Elicited Myocarditis Is Associated With Acquisition of CD62L(Low)LFA-1(High)VLA-4(High) Activation Phenotype and Expression of IFN-Gamma-Inducible Adhesion and Chemoattractant Molecules</article-title>. <source>Microbes Infect</source> (<year>2001</year>) <volume>3</volume>(<issue>12</issue>):<page-range>971&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1286-4579(01)01461-7</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reis</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Tostes</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Gazzinelli</surname> <given-names>G</given-names>
</name>
<name>
<surname>Colley</surname> <given-names>DG</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of Inflammatory Infiltrates in Chronic Chagasic Myocardial Lesions - Presence of Tumor Necrosis Factor-Alpha+ Cells and Dominance of Granzyme A+, Cd8+ Lymphocytes</article-title>. <source>Am J Trop Med Hygiene</source> (<year>1993</year>) <volume>48</volume>(<issue>5</issue>):<page-range>637&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4269/ajtmh.1993.48.637</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Murali-Krishna</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tarleton</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Generation of Trypanosoma Cruzi-Specific CD8(+) T-Cell Immunity Is Unaffected by the Absence of Type I Interferon Signaling</article-title>. <source>Infect Immun</source> (<year>2010</year>) <volume>78</volume>(<issue>7</issue>):<page-range>3154&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.00275-10</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Matthews</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yap</surname> <given-names>GS</given-names>
</name>
</person-group>. <article-title>IL-12 Signaling Drives CD8(+) T Cell IFN-Gamma Production and Differentiation of KLRG1(+) Effector Subpopulations During Toxoplasma Gondii Infection</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>(<issue>9</issue>):<page-range>5935&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.180.9.5935</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henry</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Ornelles</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Mitchell</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Brzoza-Lewis</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Hiltbold</surname> <given-names>EM</given-names>
</name>
</person-group>. <article-title>IL-12 Produced by Dendritic Cells Augments CD8(+) T Cell Activation Through the Production of the Chemokines CCL1 and CCL17</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>(<issue>12</issue>):<page-range>8576&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.181.12.8576</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Geiger</surname> <given-names>TL</given-names>
</name>
</person-group>. <article-title>IL-6 Promotes T Cell Proliferation and Expansion Under Inflammatory Conditions in Association With Low-Level ROR Gamma T Expression</article-title>. <source>J Immunol</source> (<year>2018</year>) <volume>201</volume>(<issue>10</issue>):<page-range>2934&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1800016</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanmarco</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Visconti</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Eberhardt</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ramello</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Ponce</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Spitale</surname> <given-names>NB</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-6 Improves the Nitric Oxide-Induced Cytotoxic Cd8+T Cell Dysfunction in Human Chagas Disease</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<elocation-id>626</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2016.00626</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolumam</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>S</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Sprent</surname> <given-names>J</given-names>
</name>
<name>
<surname>Murali-Krishna</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Type I Interferons Act Directly on CD8 T Cells to Allow Clonal Expansion and Memory Formation in Response to Viral Infection</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>202</volume>(<issue>5</issue>):<page-range>637&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20050821</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reis</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Higuchi</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Benvenuti</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Aiello</surname> <given-names>VD</given-names>
</name>
<name>
<surname>Gutierrez</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Bellotti</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>An <italic>In Situ</italic> Quantitative Immunohistochemical Study of Cytokines and IL-2R(+) in Chronic Human Chagasic Myocarditis: Correlation With the Presence of Myocardial Trypanosoma Cruzi Antigens</article-title>. <source>Clin Immunol Immunopathol</source> (<year>1997</year>) <volume>83</volume>(<issue>2</issue>):<page-range>165&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/clin.1997.4335</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>